
    
      In all, 30 consecutive patients will be enrolled. The first 5 will be regarded as a pilot
      series for testing and aligning the study setup. The next 25 patients will form the study
      group. The clinical outcomes will be compared with historical control patients from our own
      department. Safety and feasibility will be assessed by short-term clinical outcomes.
    
  